@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix hasPart: . @prefix RNA: . @prefix hgnc: . @prefix geneProductOf: . @prefix do: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasPart: schem:Ciglitazone, schem:SR%2011237 . sub:_2 geneProductOf: hgnc:9865; a RNA: . sub:_3 rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:_4 occursIn: do:1612, species:9606; rdf:object sub:_3; rdf:predicate belv:decreases; rdf:subject schem:2%2C2-Bis%284-glycidyloxyphenyl%29propane; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:\"2,2-Bis(4-glycidyloxyphenyl)propane\") -| (composite(a(SCHEM:Ciglitazone),a(SCHEM:\"SR 11237\")) -> r(HGNC:RARB))", "composite(a(SCHEM:Ciglitazone),a(SCHEM:\"SR 11237\")) -> r(HGNC:RARB)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "20131211" . sub:_5 prov:value "The induction of RAR beta expression by the ciglitazone and SR 11237 combination was diminished by a PPAR gamma-selective antagonist, bisphenol A diglycidyl ether."; prov:wasQuotedFrom pubmed:12839938 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12839938; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:32:04.087+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }